Testosterone Effects on Bone and Frailty

Completed · Phase 4

Conditions studied: Aging, Frailty, Osteoporosis

In brief

The purpose of this study is to assess the effects of testosterone replacement on bone density, muscle strength, physical performance, quality of life and prostate symptoms in men selected for low bone mineral density or fracture and some aspect of frailty.

Key facts

Study ID

NCT00182871

Run by

National Institute on Aging (NIA)

People needed

140

Starts

2001-11-01

Expected to finish

2007-07-01

Last updated by the study team

2009-10-30

Who can join

Age: 60 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Men over age 60 years who have sustained a femoral fracture in the preceding 3 years
• Total testosterone levels below 375 ng/dl or bioavailable testosterone levels at least 1.5 SD lower than the young adult mean
• Able to come or be brought to the University of Connecticut Health Center (UCHC) for outpatient visits

You may not qualify if…

• Prostate specific antigen level over 4.0 ng/dl or the history of prostate cancer
• Disease of bone metabolism (i.e., Paget's disease, osteomalacia, hyperparathyroidism)
• History of pituitary disease
• History of sleep apnea
• Consumption of more than 3 alcoholic drinks/day
• Use of androgen, estrogen, or DHEA in the preceding year
• Use of antiresorptive agents such as calcitonin or bisphosphonates
• Metastatic or advanced cancer
• Current chemotherapy or radiation treatment
• Plans to move in the next three years
• Advanced liver or renal disease such that the subjects is unlikely to complete the three year intervention
• Hemaglobin >16.5 g/dl
• Bilateral hip replacement or repair

Where it is running

• Center on Aging, University of Connecticut Health Center — Farmington, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.